Journal of Dual Diagnosis

Scope & Guideline

Integrating care for a healthier tomorrow.

Introduction

Immerse yourself in the scholarly insights of Journal of Dual Diagnosis with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1550-4263
PublisherROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2004 to 2024
AbbreviationJ DUAL DIAGN / J. Dual Diagn.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND

Aims and Scopes

The *Journal of Dual Diagnosis* is dedicated to advancing the understanding and treatment of individuals with co-occurring mental health and substance use disorders. The journal emphasizes integrative and interdisciplinary approaches, focusing on both clinical practices and research methodologies that address the complexities of dual diagnosis.
  1. Co-occurring Disorders Research:
    The journal publishes studies on the prevalence, characteristics, and treatment of individuals suffering from both mental health disorders and substance use disorders, highlighting their interconnectedness.
  2. Clinical Interventions and Treatment Strategies:
    It focuses on evidence-based practices and innovative treatment approaches aimed at improving outcomes for patients with dual diagnoses, including pharmacological, psychological, and psychosocial interventions.
  3. Impact of Trauma and Stress on Substance Use:
    Research exploring the role of trauma, particularly post-traumatic stress disorder (PTSD), in the development and exacerbation of substance use disorders is a core area of focus.
  4. Demographic and Sociocultural Influences:
    The journal examines how various demographic factors, such as race, gender, and socioeconomic status, influence the manifestation and treatment of dual diagnosis, aiming to address health disparities.
  5. Public Health Perspectives:
    It contributes to the discourse on public health implications of dual diagnosis, including policy impacts and community health strategies, particularly in the context of emerging issues like the COVID-19 pandemic.
Recent publications in the *Journal of Dual Diagnosis* reveal emerging trends and themes that reflect contemporary challenges and advancements in the field. These trends highlight the journal's responsiveness to evolving societal needs and research frontiers.
  1. Impact of COVID-19 on Substance Use and Mental Health:
    A significant number of recent studies have focused on how the COVID-19 pandemic has affected substance use patterns and mental health outcomes, showcasing the urgent need to adapt treatment and support mechanisms during public health crises.
  2. Use of Technology in Treatment Delivery:
    There is an increasing trend towards exploring digital interventions and telehealth solutions for managing dual diagnosis, indicating a shift towards modernizing treatment approaches to improve accessibility and engagement.
  3. Understanding Trauma's Role in Dual Diagnosis:
    Emerging research emphasizes the complexities of trauma in relation to substance use and mental health disorders, with a focus on tailored interventions addressing trauma-related symptoms.
  4. Cultural and Racial Considerations in Treatment:
    Recent publications have highlighted the importance of understanding cultural and racial factors in the treatment of dual diagnosis, striving for more inclusive and equitable healthcare practices.
  5. Innovative Treatment Modalities:
    The exploration of integrative treatment models, such as harm reduction and holistic approaches, is gaining traction, reflecting a broader acceptance of diverse strategies to address the multifaceted nature of dual diagnosis.

Declining or Waning

While the *Journal of Dual Diagnosis* continues to evolve, certain themes have shown signs of declining prominence in recent publications. This shift may reflect changing priorities in research focus or the maturation of specific topics within the field.
  1. Traditional Substance Use Treatment Models:
    There appears to be a waning emphasis on conventional treatment models that do not integrate mental health services, as newer studies increasingly advocate for holistic, dual-focused approaches.
  2. Single Disorder Studies:
    Research focusing exclusively on either substance use disorders or mental health conditions, without considering their co-occurrence, is becoming less frequent, indicating a shift towards more integrated research frameworks.
  3. Generalized Risk Factors without Contextual Analysis:
    There is a decline in studies that discuss risk factors for substance use or mental health disorders in isolation, suggesting a preference for more nuanced analyses that consider the interplay of various factors in dual diagnosis.
  4. Static Epidemiological Studies:
    Epidemiological studies that do not address contemporary issues, such as the impact of recent societal changes or the pandemic on dual diagnosis, are less represented, indicating a need for more dynamic and contextually relevant research.
  5. Focus on Non-Evidence-Based Interventions:
    Research centered on interventions lacking rigorous evidence or those that do not demonstrate efficacy in dual diagnosis contexts is decreasing, as the journal prioritizes high-quality, evidence-based studies.

Similar Journals

Suchttherapie

Empowering Minds Through Cutting-Edge Research
Publisher: GEORG THIEME VERLAG KGISSN: 1439-9903Frequency: 4 issues/year

Suchttherapie, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a critical platform within the fields of Applied Psychology and Psychiatry and Mental Health. Established in 2000 and continuing through 2024, this journal is committed to advancing the understanding and treatment of addiction and related psychological issues. Although it currently stands in the Q4 Quartile ranking and is categorized as low percentile in both Scopus Ranks and impact metrics, its significance lies in its dedication to disseminating cutting-edge research and clinical findings that contribute to the evolving landscape of therapeutic practices. Published in Germany, the journal facilitates unlimited access to the vital discourse surrounding mental health and addiction treatment, making it a valuable resource for researchers, professionals, and students alike seeking to enhance their knowledge and skills in this important area of study. As the field continues to grow, Suchttherapie plays a pivotal role in bridging practice with academic rigor, ensuring that readers remain informed on the latest methodologies and insights.

AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Navigating the Intersection of Psychology and Addiction
Publisher: TAYLOR & FRANCIS INCISSN: 0095-2990Frequency: 6 issues/year

American Journal of Drug and Alcohol Abuse is a highly regarded publication in the field of substance abuse research, published by Taylor & Francis Inc. With its inception in 1974, this journal has become an essential resource for scholars and practitioners interested in clinical psychology, psychiatry, and the multifaceted issues surrounding drug and alcohol use. It holds a notable Q2 ranking in Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, emphasizing its impact and relevance in these domains. The journal's 2023 Scopus rankings further highlight its standing, placing it in the top quartile of publications with established readership and citation metrics. Researchers and students can benefit from its comprehensive articles that delve into the complexities of substance use, treatment methodologies, and the socio-psychological underpinnings of addiction. Whether you seek to access cutting-edge studies or contribute to ongoing discourse in the field, the American Journal of Drug and Alcohol Abuse serves as a vital hub for knowledge dissemination and scholarly engagement.

Therapeutic Communities

Exploring the impact of community on mental health.
Publisher: EMERALD GROUP PUBLISHING LTDISSN: 0964-1866Frequency: 4 issues/year

Therapeutic Communities, a publication of EMERALD GROUP PUBLISHING LTD, has been a significant contributor to the fields of clinical psychology, psychiatry, and mental health since its inception in 1992. With the ISSN 0964-1866 and E-ISSN 2052-4730, this journal aims to disseminate innovative research and comprehensive reviews that advance our understanding of therapeutic communities and their impact on psychological well-being. Although currently ranked in the Q4 category for Clinical Psychology and Health Professions, the journal continues to strive towards elevating scholarly discourse and practice in mental health settings. Located in the United Kingdom, the journal does not offer open access, but its content remains vital for researchers and practitioners seeking to explore therapeutic modalities and community-based interventions. As the landscape of mental health care evolves, Therapeutic Communities stands as a crucial platform for sharing insights and fostering collaboration among professionals in this essential domain.

DRUG AND ALCOHOL DEPENDENCE

Transforming insights into action against substance use.
Publisher: ELSEVIER IRELAND LTDISSN: 0376-8716Frequency: 12 issues/year

Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.

JOURNAL OF SUBSTANCE ABUSE TREATMENT

Empowering Research for Effective Recovery Solutions
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0740-5472Frequency: 12 issues/year

JOURNAL OF SUBSTANCE ABUSE TREATMENT, published by Pergamon-Elsevier Science Ltd, is a leading peer-reviewed journal that spans a wide range of topics related to substance abuse and addiction treatments. With an impressive impact factor, this esteemed journal ranks in the Q1 quartile across multiple disciplines including Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, making it a vital resource for researchers and practitioners alike. Covering convergence years from 1984 to 2023, it publishes cutting-edge research that informs treatment methodologies and policy development in the field of substance abuse. With access options that adapt to both traditional and modern academic needs, the journal seeks to advance the understanding and effectiveness of substance abuse treatment through comprehensive studies and innovative approaches. Be part of a global dialogue that shapes the future of addiction treatment by engaging with the latest findings and expert analyses that help bridge the gap between research and clinical practice.

Middle East Current Psychiatry-MECPsych

Exploring the intersection of culture and psychiatry.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Middle East Current Psychiatry (MECPsych), published by SpringerNature, is a prominent open-access journal dedicated to advancing the field of psychiatry and mental health in the Middle East and beyond. Since its establishment in 2011, MECPsych has aimed to disseminate high-quality research, reviews, and reports that capture recent developments in psychiatric science, clinical practice, and public health considerations in mental well-being. With an impact factor reflective of its growing influence and classified in the Q3 quartile for Psychiatry and Mental Health, the journal offers invaluable insights backed by rigorous peer review processes. Operating under an open access model since 2019, MECPsych ensures that its articles are freely accessible to a global readership, enhancing the visibility and application of research findings. As part of its ongoing commitment to enriching understanding in the field, MECPsych also encourages submissions that explore the unique cultural, societal, and economic factors influencing mental health across the region. This approach not only supports researchers, professionals, and students in their pursuit of knowledge but also fosters a collaborative dialogue among mental health stakeholders in the Middle East and around the world.

Klinik Psikiyatri Dergisi-Turkish Journal of Clinical Psychiatry

Innovating Insights in Mental Health Research
Publisher: KLINIK PSIKIYATRI DERGISIISSN: 1302-0099Frequency: 4 issues/year

Klinik Psikiyatri Dergisi - Turkish Journal of Clinical Psychiatry is a distinguished open-access journal dedicated to the evolving field of psychiatry and mental health. Published by KLINIK PSIKIYATRI DERGISI in Turkey since 1998, this journal aims to provide a platform for the dissemination of research, clinical studies, and reviews that contribute to the understanding of psychological disorders and treatment methodologies. With an ISSN of 1302-0099 and an E-ISSN of 2146-7153, the journal is indexed in various databases, although it currently holds a rank of 460/567 in the Scopus ranking for the category of Medicine: Psychiatry and Mental Health. The journal operates under an open-access model, ensuring that research findings are readily accessible to a wide audience, contributing to greater knowledge and awareness in the field. As it converges from 2017 to 2024, Klinik Psikiyatri Dergisi continues to strive for excellence, providing valuable insights and resources for researchers, professionals, and students interested in the complexities of mental health.

Current Addiction Reports

Exploring the frontiers of clinical psychology and psychiatry.
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Addiction Reports, published by SPRINGERNATURE, is a leading journal dedicated to the comprehensive study of addiction in its various dimensions, with a particular focus on the latest clinical developments and research in Clinical Psychology and Psychiatry and Mental Health. Since its inception in 2014 and through to 2024, the journal has established itself as a pivotal resource for researchers, professionals, and students alike, currently holding a prestigious Q1 ranking in both relevant categories. With an impressive Scopus rank of #46 in Clinical Psychology and #129 in Psychiatry and Mental Health, it occupies a significant position within the field, reflecting its commitment to high-quality scholarship and impactful findings. The journal offers open access options, ensuring that vital research is readily available to a global audience. By fostering a deeper understanding of addiction trends and innovative treatment methodologies, Current Addiction Reports plays an essential role in advancing knowledge and improving clinical practices.

Asia-Pacific Psychiatry

Shaping the Future of Psychiatry with Impactful Research
Publisher: WILEYISSN: 1758-5864Frequency: 4 issues/year

Asia-Pacific Psychiatry is a leading academic journal published by WILEY, focused on the diverse and rapidly evolving fields of psychiatry and mental health within the Asia-Pacific region. With an ISSN of 1758-5864 and an E-ISSN of 1758-5872, this journal has been recognized for its significant impact, holding a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in Psychiatry and Mental Health as of 2023. Its commendable Scopus ranking places it at Rank #83 out of 567 in its category, highlighting its influence and relevance in contemporary research. The journal aims to facilitate the dissemination of high-quality research, reviews, and clinical insights that address mental health challenges, promote global understanding, and encourage collaboration among professionals and academics. Although it is not an open-access journal, the high impact factor underscores its value in the scholarly community, making it an essential resource for researchers, clinicians, and students dedicated to enhancing mental health practices and policies in the region and beyond.

DRUG AND ALCOHOL REVIEW

Illuminating the path to effective substance use solutions.
Publisher: WILEYISSN: 0959-5236Frequency: 6 issues/year

DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.